Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms

RNA vaccines represent a milestone in the history of vaccinology. They provide several advantages over more traditional approaches to vaccine development, showing strong immunogenicity and an overall favorable safety profile. While preclinical testing has provided some key insights on how RNA vaccines interact with the innate immune system, their mechanism of action appears to be fragmented amid the literature, making it difficult to formulate new hypotheses to be tested in clinical settings and ultimately improve this technology platform. Here, we propose a systems biology approach, based on the combination of literature mining and mechanistic graphical modeling, to consolidate existing knowledge around mRNA vaccines mode of action and enhance the translatability of preclinical hypotheses into clinical evidence. A Natural Language Processing (NLP) pipeline for automated knowledge extraction retrieved key biological evidences that were joined into an interactive mechanistic graphical model representing the chain of immune events induced by mRNA vaccines administration. The achieved mechanistic graphical model will help the design of future experiments, foster the generation of new hypotheses and set the basis for the development of mathematical models capable of simulating and predicting the immune response to mRNA vaccines.

[1]  Fei Wang,et al.  Recent advances in biomedical literature mining , 2020, Briefings Bioinform..

[2]  Corrado Priami,et al.  High-Precision Biomedical Relation Extraction for Reducing Human Curation Efforts in Industrial Applications , 2020, IEEE Access.

[3]  I. Ferlenghi,et al.  Mannosylation of LNP results in improved potency for self-amplifying RNA (SAM) vaccines. , 2019, ACS infectious diseases.

[4]  E. Frigimelica,et al.  Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines. , 2019, Vaccine.

[5]  C. Zurla,et al.  Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging , 2019, Nature Biomedical Engineering.

[6]  Christian Simon,et al.  BioReader: a text mining tool for performing classification of biomedical literature , 2019, BMC Bioinformatics.

[7]  Indra Neil Sarkar,et al.  Machine learning approach to literature mining for the genetics of complex diseases , 2019, Database J. Biol. Databases Curation.

[8]  D. Weissman,et al.  Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses , 2018, The Journal of experimental medicine.

[9]  D. Weissman,et al.  mRNA vaccines — a new era in vaccinology , 2018, Nature Reviews Drug Discovery.

[10]  E. Ramanculov,et al.  Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector , 2017, PloS one.

[11]  Ö. Türeci,et al.  Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins , 2017, Human gene therapy.

[12]  Kimberly J. Hassett,et al.  Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells , 2017, Front. Immunol..

[13]  M. Fotin‐Mleczek,et al.  Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines , 2017, npj Vaccines.

[14]  Kimberly J. Hassett,et al.  Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  Vinaitheerthan Renganathan,et al.  Text Mining in Biomedical Domain with Emphasis on Document Clustering , 2017, Healthcare informatics research.

[16]  Jason C Debasitis,et al.  Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design , 2017, The Journal of Immunology.

[17]  Pengpeng Xia,et al.  RNA sensors of the innate immune system and their detection of pathogens , 2017, IUBMB life.

[18]  J. Rosenecker,et al.  Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems , 2017, Gene Therapy.

[19]  M. Fotin‐Mleczek,et al.  Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response , 2017, Journal of Translational Medicine.

[20]  Daniel G. Anderson,et al.  Materials for non-viral intracellular delivery of messenger RNA therapeutics. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[21]  S. Bertholet,et al.  Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge , 2016, PloS one.

[22]  J. Ulmer,et al.  Recent innovations in mRNA vaccines. , 2016, Current opinion in immunology.

[23]  P. Mason,et al.  Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin , 2015, Journal of Virology.

[24]  C. Buonsanti,et al.  CD8 T‐cell priming upon mRNA vaccination is restricted to bone‐marrow‐derived antigen‐presenting cells and may involve antigen transfer from myocytes , 2015, Immunology.

[25]  T. Schlake,et al.  Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  H. Liao,et al.  Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion. , 2015, The Journal of infectious diseases.

[27]  G. Vanham,et al.  Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  S. Akira,et al.  Activation of MDA5 Requires Higher-Order RNA Structures Generated during Virus Infection , 2009, Journal of Virology.

[29]  Hiroki Kato,et al.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[31]  Sophia Ananiadou,et al.  Text Mining for Biology And Biomedicine , 2005 .

[32]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.